Tanabe Research Laboratories
4540 Towne Centre Court
About Tanabe Research Laboratories
Tanabe Research Laboratories is dedicated to the discovery and early-stage development of innovative biological drugs that will improve the lives of patients around the world.
Established in 1994, Tanabe Research Laboratories is an independent subsidiary of Japan-based Mitsubishi Tanabe Pharmaceutical Corp. Our focus is creating safe and effective therapies for cancer and other life-threatening diseases.
Following the merger of Mitsubishi Pharmaceutical Corporation and Tanabe Pharmaceuticals, Tanabe Research Laboratories in 2010 transitioned into a biologics-driven research facility concentrating on oncology and other diseases with unmet clinical needs.
Since then, we have expanded to encompass not only research activities, but also early-stage clinical evaluation of therapeutic drugs. In addition to our internal drug development activities, we actively partner with pharmaceutical companies and research organizations.
7 articles with Tanabe Research Laboratories
Ablexis grants rights to use the AlivaMab ® Mouse platform for research, development and commercialization of antibodies
MedImmune And Tanabe Research Laboratories U.S.A., Inc./Mitsubishi Tanabe Enter Into Strategic Collaboration And Licensing Agreement For The Development Of Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugates To Treat Cancer
Covagen And Tanabe Research Laboratories U.S.A., Inc. Expand Strategic Research Collaboration For Development Of Bispecific FynomAbs
X-BODY Biosciences Enters Into R&D Partnership With Tanabe Research Laboratories U.S.A., Inc. to Generate Antibody Therapeutics for Autoimmune Disorders
Anaphore, Inc. Snags $110M Deal With Tanabe Research Laboratories U.S.A., Inc. to Make Drugs for Immune Disorders
Mitsubishi Tanabe Pharma Corporation Cuts Jobs at Tanabe Research Laboratories U.S.A., Inc.; Sets New Course for La Jolla Laboratories